- Biotech Companies Hunt for Cash as VC Funding Dries Up Bloomberg
- How 2 biotechs survived 2022’s rocky market—and why their CEOs see success on the horizon FierceBiotech
- Upstart Drug Companies Are Scrambling for Cash Bloomberg
- The Money Tree for Biotech Startups Loses Its Leaves Bloomberg
- View Full coverage on Google News
The wire
More investor news
Venture units die in budget meetings. Procurement can keep them alive – Global Venturing
UK Sovereign AI fund and Stripe CEO back Potential Sciences in multi-million-dollar raise – Tech.eu
Inside the race to build European hardware without China – Sifted
Five UK startups secure eight patents from Panasonic, Nokia, NEC and DENSO – Tech.eu
Claimlane bags €5.6M to turn product claims into business value – Tech.eu
Early Revolut employees emerge from stealth with AI wealthtech Haido – Sifted